118 related articles for article (PubMed ID: 24788529)
1. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition.
De Petris G; Dhungel BM; Chen L; Chang YH
Int J Surg Pathol; 2014 Oct; 22(7):600-6. PubMed ID: 24788529
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.
Daniels JA; Lederman HM; Maitra A; Montgomery EA
Am J Surg Pathol; 2007 Dec; 31(12):1800-12. PubMed ID: 18043034
[TBL] [Abstract][Full Text] [Related]
3. Gastric adenocarcinoma occurring in a young patient with common variable immunodeficiency syndrome.
Yap YL; So JB
Singapore Med J; 2009 Jun; 50(6):e201-3. PubMed ID: 19551296
[TBL] [Abstract][Full Text] [Related]
4. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
5. Gastric pathology in patients with common variable immunodeficiency.
Zullo A; Romiti A; Rinaldi V; Vecchione A; Tomao S; Aiuti F; Frati L; Luzi G
Gut; 1999 Jul; 45(1):77-81. PubMed ID: 10369708
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer Screening in Common Variable Immunodeficiency.
van der Poorten DK; McLeod D; Ahlenstiel G; Read S; Kwok A; Santhakumar C; Bassan M; Culican S; Campbell D; Wong SWJ; Evans L; Jideh B; Kane A; Katelaris CH; Keat K; Ko Y; Lee JA; Limaye S; Lin MW; Murad A; Rafferty M; Suan D; Swaminathan S; Riminton SD; Toong C; Berglund LJ
J Clin Immunol; 2018 Oct; 38(7):768-777. PubMed ID: 30219982
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A
J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683
[TBL] [Abstract][Full Text] [Related]
8. Gastroduodenal Disorders in Patients with CVID Undergoing Immunoglobulin Therapy.
Varricchi G; Pecoraro A; Crescenzi L; Marone G; Travaglino A; D'Armiento FP; Genovese A; Spadaro G
Curr Pharm Biotechnol; 2018; 19(9):734-741. PubMed ID: 30336770
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
[TBL] [Abstract][Full Text] [Related]
10. Histology of gastric antrum in intestinal-type gastric adenocarcinoma from Asir Central Hospital, Saudi Arabia.
Morad NA
East Afr Med J; 1995 Sep; 72(9):577-8. PubMed ID: 7498044
[TBL] [Abstract][Full Text] [Related]
11. Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.
Pulvirenti F; Pecoraro A; Cinetto F; Milito C; Valente M; Santangeli E; Crescenzi L; Rizzo F; Tabolli S; Spadaro G; Agostini C; Quinti I
Front Immunol; 2018; 9():2546. PubMed ID: 30455695
[TBL] [Abstract][Full Text] [Related]
12. Endoscopical and histological features in bile reflux gastritis.
Vere CC; Cazacu S; Comănescu V; Mogoantă L; Rogoveanu I; Ciurea T
Rom J Morphol Embryol; 2005; 46(4):269-74. PubMed ID: 16688361
[TBL] [Abstract][Full Text] [Related]
13. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer.
Gullo I; Costa C; Silva SL; Ferreira C; Motta A; Silva SP; Ferreira RD; Rosmaninho P; Faria E; Costa JTD; Câmara R; Gonçalves G; Santos-Antunes J; Oliveira C; Machado JC; Carneiro F; Sousa AE
Cells; 2020 Jun; 9(6):. PubMed ID: 32575504
[TBL] [Abstract][Full Text] [Related]
14. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
15. The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer.
Jang TJ
Pathol Res Pract; 2010 Jan; 206(1):34-8. PubMed ID: 19819643
[TBL] [Abstract][Full Text] [Related]
16. [Precancerous lesions associated with atrophic chronic gastritis and gastric peptic ulcer].
Nogueira AM; Barbosa CS; Miranda D
Arq Gastroenterol; 1982; 19(4):169-74. PubMed ID: 7186401
[TBL] [Abstract][Full Text] [Related]
17. The gastric mucosa in gastric cancer patients in a low-incidence area.
Genta RM; Pusztaszeri M
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1085-93. PubMed ID: 16957515
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
19. Background submucosal cysts in early gastric cancer cases have unique clinicopathologic features suggestive of postgastritis and significant smoking association.
Ichinoe M; Mikami T; Hara A; Tsuruta T; Okayasu I
Am J Clin Pathol; 2007 Nov; 128(5):746-52. PubMed ID: 17951195
[TBL] [Abstract][Full Text] [Related]
20. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]